rare cancer

Read news on rare cancer with our app.

Read more in the app

Mystery Solved: Surprising Origins for a Rare Cancer Uncovered

Surprising origins for a rare cancer

Surprising origins for a rare cancer - EurekAlert

Scientists excited by AI tool that grades severity of rare cancer

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.